Crescentic Glomerulonephritis: New Aspects of Pathogenesis

Seminars in Nephrology

Volumn 31, Issue 4, 2011, Pages 361-368

  Tarzi, Ruth M ^a   Cook, H Terence ^a   Pusey, Charles D ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

ANCA associated vasculitis; Anti GBM antibodies; Antineutrophil cytoplasm antibodies; Crescentic glomerulonephritis; Goodpasture disease

Indexed keywords

AUTOANTIGEN; CD30 ANTIGEN; COLLAGEN TYPE 4; COTRIMOXAZOLE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; HLA ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 17; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 8; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN; MYELOBLASTIN; MYELOPEROXIDASE; NEOPTERIN; NEUTROPHIL CYTOPLASMIC ANTIBODY; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22;

ANCA ASSOCIATED VASCULITIS; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CYTOKINE RELEASE; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GLOMERULONEPHRITIS; GOODPASTURE SYNDROME; HUMAN; IMMUNE COMPLEX NEPHRITIS; LUNG HEMORRHAGE; MOLECULAR MIMICRY; MONOCYTE; NONHUMAN; PATHOGENESIS; PATHOGENICITY; PRIORITY JOURNAL; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; REGULATORY T LYMPHOCYTE; RISK FACTOR; STAPHYLOCOCCUS INFECTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH17 CELL;

ANIMALS; ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; AUTOANTIBODIES; GLOMERULONEPHRITIS; HUMANS; LYMPHOCYTE ACTIVATION; LYSOSOME-ASSOCIATED MEMBRANE GLYCOPROTEINS; PEROXIDASE; T-LYMPHOCYTES;

EID: 79961219048     PISSN: 02709295     EISSN: 15584488     Source Type: Journal    
DOI: 10.1016/j.semnephrol.2011.06.007     Document Type: Article

References (94)

1. Hoffman G.S., Kerr G.S., Leavitt R.Y., Hallahan C.W., Lebovics R.S., Travis W.D., et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 1992, 116:488-498.
2. Booth A.D., Almond M.K., Burns A., Ellis P., Gaskin G., Neild G.H., et al. Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study. Am J Kidney Dis 2003, 41:776-784.
3. Savige J., Davies D., Falk R.J., Jennette J.C., Wiik A. Antineutrophil cytoplasmic antibodies and associated diseases: a review of the clinical and laboratory features. Kidney Int 2000, 57:846-862.
4. Davies D.J., Moran J.E., Niall J.F., Ryan G.B. Segmental necrotising glomerulonephritis with antineutrophil antibody: possible arbovirus aetiology?. Br Med J (Clin Res Ed) 1982, 285:606.
5. van der Woude F.J., Rasmussen N., Lobatto S., Wiik A., Permin H., van Es L.A., et al. Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 1985, 1:425-429.
6. Ludemann J., Utecht B., Gross W.L. Anti-cytoplasmic antibodies in Wegener's granulomatosis are directed against proteinase 3. Adv Exp Med Biol 1991, 297:141-150.
7. Falk R.J., Jennette J.C. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 1988, 318:1651-1657.
8. Tervaert J.W., van der Woude F.J., Fauci A.S., Ambrus J.L., Velosa J., Keane W.F., et al. Association between active Wegener's granulomatosis and anticytoplasmic antibodies. Arch Intern Med 1989, 149:2461-2465.
9. Boomsma M.M., Stegeman C.A., van der Leij M.J., Oost W., Hermans J., Kallenberg C.G., et al. Prediction of relapses in Wegener's granulomatosis by measurement of antineutrophil cytoplasmic antibody levels: a prospective study. Arthritis Rheum 2000, 43:2025-2033.
10. Choi H.K., Liu S., Merkel P.A., Colditz G.A., Niles J.L. Diagnostic performance of antineutrophil cytoplasmic antibody tests for idiopathic vasculitides: metaanalysis with a focus on antimyeloperoxidase antibodies. J Rheumatol 2001, 28:1584-1590.
11. Williams J.M., Ben-Smith A., Hewins P., Dove S.K., Hughes P., McEwan R., et al. Activation of the G(i) heterotrimeric G protein by ANCA IgG F(ab')2 fragments is necessary but not sufficient to stimulate the recruitment of those downstream mediators used by intact ANCA IgG. J Am Soc Nephrol 2003, 14:661-669.
12. Mulder A.H., Heeringa P., Brouwer E., Limburg P.C., Kallenberg C.G. Activation of granulocytes by anti-neutrophil cytoplasmic antibodies (ANCA): a Fc gamma RII-dependent process. Clin Exp Immunol 1994, 98:270-278.
13. Harper L., Cockwell P., Adu D., Savage C.O. Neutrophil priming and apoptosis in anti-neutrophil cytoplasmic autoantibody-associated vasculitis. Kidney Int 2001, 59:1729-1738.
14. Hattar K., Bickenbach A., Csernok E., Rosseau S., Grandel U., Seeger W., et al. Wegener's granulomatosis: antiproteinase 3 antibodies induce monocyte cytokine and prostanoid release-role of autocrine cell activation. J Leukoc Biol 2002, 71:996-1004.
15. Savage C.O., Pottinger B.E., Gaskin G., Pusey C.D., Pearson J.D. Autoantibodies developing to myeloperoxidase and proteinase 3 in systemic vasculitis stimulate neutrophil cytotoxicity toward cultured endothelial cells. Am J Pathol 1992, 141:335-342.
16. Radford D.J., Savage C.O., Nash G.B. Treatment of rolling neutrophils with antineutrophil cytoplasmic antibodies causes conversion to firm integrin-mediated adhesion. Arthritis Rheum 2000, 43:1337-1345.
17. Harper L., Ren Y., Savill J., Adu D., Savage C.O. Antineutrophil cytoplasmic antibodies induce reactive oxygen-dependent dysregulation of primed neutrophil apoptosis and clearance by macrophages. Am J Pathol 2000, 157:211-220.
18. Chavele K.M., Shukla D., Keteepe-Arachi T., Seidel J.A., Fuchs D., Pusey C.D., et al. Regulation of myeloperoxidase-specific T cell responses during disease remission in antineutrophil cytoplasmic antibody-associated vasculitis: the role of Treg cells and tryptophan degradation. Arthritis Rheum 2010, 62:1539-1548.
19. Muller Kobold A.C., Kallenberg C.G., Tervaert J.W. Monocyte activation in patients with Wegener's granulomatosis. Ann Rheum Dis 1999, 58:237-245.
20. van Timmeren M.M., van der Veen B.S., Stegeman C.A., Petersen A.H., Hellmark T., Collin M., et al. IgG glycan hydrolysis attenuates ANCA-mediated glomerulonephritis. J Am Soc Nephrol 2010, 21:1103-1114.
21. Bansal P.J., Tobin M.C. Neonatal microscopic polyangiitis secondary to transfer of maternal myeloperoxidase-antineutrophil cytoplasmic antibody resulting in neonatal pulmonary hemorrhage and renal involvement. Ann Allergy Asthma Immunol 2004, 93:398-401.
22. Little M.A., Smyth L., Salama A.D., Mukherjee S., Smith J., Haskard D., et al. Experimental autoimmune vasculitis: an animal model of anti-neutrophil cytoplasmic autoantibody-associated systemic vasculitis. Am J Pathol 2009, 174:1212-1220.
23. Little M.A., Smyth C.L., Yadav R., Ambrose L., Cook H.T., Nourshargh S., et al. Antineutrophil cytoplasm antibodies directed against myeloperoxidase augment leukocyte-microvascular interactions in vivo. Blood 2005, 106:2050-2058.
24. Xiao H., Heeringa P., Hu P., Liu Z., Zhao M., Aratani Y., et al. Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest 2002, 110:955-963.
25. Xiao H., Heeringa P., Liu Z., Huugen D., Hu P., Maeda N., et al. The role of neutrophils in the induction of glomerulonephritis by anti-myeloperoxidase antibodies. Am J Pathol 2005, 167:39-45.
26. Xiao H., Schreiber A., Heeringa P., Falk R.J., Jennette J.C. Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodies. Am J Pathol 2007, 170:52-64.
27. Summers S.A., van der Veen B.S., O'Sullivan K.M., Gan P.Y., Ooi J.D., Heeringa P., et al. Intrinsic renal cell and leukocyte-derived TLR4 aggravate experimental anti-MPO glomerulonephritis. Kidney Int 2010, 78:1263-1274.
28. Pfister H., Ollert M., Frohlich L.F., Quintanilla-Martinez L., Colby T.V., Specks U., et al. Antineutrophil cytoplasmic autoantibodies against the murine homolog of proteinase 3 (Wegener autoantigen) are pathogenic in vivo. Blood 2004, 104:1411-1418.
29. Pinching A.J., Rees A.J., Pussell B.A., Lockwood C.M., Mitchison R.S., Peters D.K. Relapses in Wegener's granulomatosis: the role of infection. Br Med J 1980, 281:836-838.
30. Stegeman C.A., Tervaert J.W., Sluiter W.J., Manson W.L., de Jong P.E., Kallenberg C.G. Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener granulomatosis. Ann Intern Med 1994, 120:12-17.
31. Kallenberg C.G., Stegeman C.A., Tervaert J.W. Staphylococcus aureus, trimethoprim-sulfamethoxazole, and Wegener's granulomatosis. Sarcoidosis Vasc Diffuse Lung Dis 1996, 13:253-255.
32. Pendergraft W.F., Preston G.A., Shah R.R., Tropsha A., Carter C.W., Jennette J.C., et al. Autoimmunity is triggered by cPR-3(105-201), a protein complementary to human autoantigen proteinase-3. Nat Med 2004, 10:72-79.
33. Kain R., Matsui K., Exner M., Binder S., Schaffner G., Sommer E.M., et al. A novel class of autoantigens of anti-neutrophil cytoplasmic antibodies in necrotizing and crescentic glomerulonephritis: the lysosomal membrane glycoprotein h-lamp-2 in neutrophil granulocytes and a related membrane protein in glomerular endothelial cells. J Exp Med 1995, 181:585-597.
34. Cunningham M.A., Huang X.R., Dowling J.P., Tipping P.G., Holdsworth S.R. Prominence of cell-mediated immunity effectors in "pauci-immune" glomerulonephritis. J Am Soc Nephrol 1999, 10:499-506.
35. Griffith M.E., Coulthart A., Pusey C.D. T cell responses to myeloperoxidase (MPO) and proteinase 3 (PR3) in patients with systemic vasculitis. Clin Exp Immunol 1996, 103:253-258.
36. King W.J., Brooks C.J., Holder R., Hughes P., Adu D., Savage C.O. T lymphocyte responses to anti-neutrophil cytoplasmic autoantibody (ANCA) antigens are present in patients with ANCA-associated systemic vasculitis and persist during disease remission. Clin Exp Immunol 1998, 112:539-546.
37. Popa E.R., Franssen C.F., Limburg P.C., Huitema M.G., Kallenberg C.G., Tervaert J.W. In vitro cytokine production and proliferation of T cells from patients with anti-proteinase 3- and antimyeloperoxidase-associated vasculitis, in response to proteinase 3 and myeloperoxidase. Arthritis Rheum 2002, 46:1894-1904.
38. Schmitt W.H., Hagen E.C., Neumann I., Nowack R., Flores-Suarez L.F., van der Woude F.J. Treatment of refractory Wegener's granulomatosis with antithymocyte globulin (ATG): an open study in 15 patients. Kidney Int 2004, 65:1440-1448.
39. Walsh M., Chaudhry A., Jayne D. Long-term follow-up of relapsing/refractory anti-neutrophil cytoplasm antibody associated vasculitis treated with the lymphocyte depleting antibody alemtuzumab (CAMPATH-1H). Ann Rheum Dis 2008, 67:1322-1327.
40. Sanders J.S., Huitma M.G., Kallenberg C.G., Stegeman C.A. Plasma levels of soluble interleukin 2 receptor, soluble CD30, interleukin 10 and B cell activator of the tumour necrosis factor family during follow-up in vasculitis associated with proteinase 3-antineutrophil cytoplasmic antibodies: associations with disease activity and relapse. Ann Rheum Dis 2006, 65:1484-1489.
41. Abdulahad W.H., van der Geld Y.M., Stegeman C.A., Kallenberg C.G. Persistent expansion of CD4+ effector memory T cells in Wegener's granulomatosis. Kidney Int 2006, 70:938-947.
42. Sallusto F., Geginat J., Lanzavecchia A. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu Rev Immunol 2004, 22:745-763.
43. McKinney E.F., Lyons P.A., Carr E.J., Hollis J.L., Jayne D.R., Willcocks L.C., et al. A CD8+ T cell transcription signature predicts prognosis in autoimmune disease. Nat Med 2010, 16:586-591. 1p following 591.
44. Nogueira E., Hamour S., Sawant D., Henderson S., Mansfield N., Chavele K.M., et al. Serum IL-17 and IL-23 levels and autoantigen-specific Th17 cells are elevated in patients with ANCA-associated vasculitis. Nephrol Dial Transplant 2010, 25:2209-2217.
45. Saito H., Tsurikisawa N., Tsuburai T., Oshikata C., Akiyama K. Cytokine production profile of CD4+ T cells from patients with active Churg-Strauss syndrome tends toward Th17. Int Arch Allergy Immunol 2009, 149(Suppl 1):61-65.
46. Abdulahad W.H., Stegeman C.A., Limburg P.C., Kallenberg C.G. Skewed distribution of Th17 lymphocytes in patients with Wegener's granulomatosis in remission. Arthritis Rheum 2008, 58:2196-2205.
47. Gan P.Y., Steinmetz O.M., Tan D.S., O'Sullivan K.M., Ooi J.D., Iwakura Y., et al. Th17 cells promote autoimmune anti-myeloperoxidase glomerulonephritis. J Am Soc Nephrol 2010, 21:925-931.
48. Morgan M.D., Day C.J., Piper K.P., Khan N., Harper L., Moss P.A., et al. Patients with Wegener's granulomatosis demonstrate a relative deficiency and functional impairment of T-regulatory cells. Immunology 2010, 130:64-73.
49. Knight A., Sandin S., Askling J. Risks and relative risks of Wegener's granulomatosis among close relatives of patients with the disease. Arthritis Rheum 2008, 58:302-307.
50. Willcocks L.C., Lyons P.A., Rees A.J., Smith K.G. The contribution of genetic variation and infection to the pathogenesis of ANCA-associated systemic vasculitis. Arthritis Res Ther 2010, 12:202.
51. Jagiello P., Gencik M., Arning L., Wieczorek S., Kunstmann E., Csernok E., et al. New genomic region for Wegener's granulomatosis as revealed by an extended association screen with 202 apoptosis-related genes. Hum Genet 2004, 114:468-477.
52. Heckmann M., Holle J.U., Arning L., Knaup S., Hellmich B., Nothnagel M., et al. The Wegener's granulomatosis quantitative trait locus on chromosome 6p21.3 as characterised by tagSNP genotyping. Ann Rheum Dis 2008, 67:972-979.
53. Stassen P.M., Cohen-Tervaert J.W., Lems S.P., Hepkema B.G., Kallenberg C.G., Stegeman C.A. HLA-DR4, DR13(6) and the ancestral haplotype A1B8DR3 are associated with ANCA-associated vasculitis and Wegener's granulomatosis. Rheumatology (Oxford) 2009, 48:622-625.
54. Spencer S.J., Burns A., Gaskin G., Pusey C.D., Rees A.J. HLA class II specificities in vasculitis with antibodies to neutrophil cytoplasmic antigens. Kidney Int 1992, 41:1059-1063.
55. Carr E.J., Clatworthy M.R., Lowe C.E., Todd J.A., Wong A., Vyse T.J., et al. Contrasting genetic association of IL2RA with SLE and ANCA-associated vasculitis. BMC Med Genet 2009, 10:22.
56. Carr E.J., Niederer H.A., Williams J., Harper L., Watts R.A., Lyons P.A., et al. Confirmation of the genetic association of CTLA4 and PTPN22 with ANCA-associated vasculitis. BMC Med Genet 2009, 10:121.
57. Kamesh L., Heward J.M., Williams J.M., Gough S.C., Chavele K.M., Salama A., et al. CT60 and +49 polymorphisms of CTLA 4 are associated with ANCA-positive small vessel vasculitis. Rheumatology (Oxford) 2009, 48:1502-1505.
58. Esnault V.L., Testa A., Audrain M., Roge C., Hamidou M., Barrier J.H., et al. Alpha 1-antitrypsin genetic polymorphism in ANCA-positive systemic vasculitis. Kidney Int 1993, 43:1329-1332.
59. Griffith M.E., Lovegrove J.U., Gaskin G., Whitehouse D.B., Pusey C.D. C-antineutrophil cytoplasmic antibody positivity in vasculitis patients is associated with the Z allele of alpha-1-antitrypsin, and P-antineutrophil cytoplasmic antibody positivity with the S allele. Nephrol Dial Transplant 1996, 11:438-443.
60. Yang J.J., Pendergraft W.F., Alcorta D.A., Nachman P.H., Hogan S.L., Thomas R.P., et al. Circumvention of normal constraints on granule protein gene expression in peripheral blood neutrophils and monocytes of patients with antineutrophil cytoplasmic autoantibody-associated glomerulonephritis. J Am Soc Nephrol 2004, 15:2103-2114.
61. Ohlsson S., Hellmark T., Pieters K., Sturfelt G., Wieslander J., Segelmark M. Increased monocyte transcription of the proteinase 3 gene in small vessel vasculitis. Clin Exp Immunol 2005, 141:174-182.
62. Ciavatta D.J., Yang J., Preston G.A., Badhwar A.K., Xiao H., Hewins P., et al. Epigenetic basis for aberrant upregulation of autoantigen genes in humans with ANCA vasculitis. J Clin Invest 2010, 120:3209-3219.
63. Saus J., Wieslander J., Langeveld J.P., Quinones S., Hudson B.G. Identification of the Goodpasture antigen as the alpha 3(IV) chain of collagen IV. J Biol Chem 1988, 263:13374-13380.
64. Ryan J.J., Mason P.J., Pusey C.D., Turner N. Recombinant alpha-chains of type IV collagen demonstrate that the amino terminal of the Goodpasture autoantigen is crucial for antibody recognition. Clin Exp Immunol 1998, 113:17-27.
65. Pedchenko V., Bondar O., Fogo A.B., Vanacore R., Voziyan P., Kitching A.R., et al. Molecular architecture of the Goodpasture autoantigen in anti-GBM nephritis. N Engl J Med 2010, 363:343-354.
66. Borza D.B., Bondar O., Todd P., Sundaramoorthy M., Sado Y., Ninomiya Y., et al. Quaternary organization of the goodpasture autoantigen, the alpha 3(IV) collagen chain. Sequestration of two cryptic autoepitopes by intrapromoter interactions with the alpha4 and alpha5 NC1 domains. J Biol Chem 2002, 277:40075-40083.
67. Borza D.B., Bondar O., Colon S., Todd P., Sado Y., Neilson E.G., et al. Goodpasture autoantibodies unmask cryptic epitopes by selectively dissociating autoantigen complexes lacking structural reinforcement: novel mechanisms for immune privilege and autoimmune pathogenesis. J Biol Chem 2005, 280:27147-27154.
68. Stevenson A., Yaqoob M., Mason H., Pai P., Bell G.M. Biochemical markers of basement membrane disturbances and occupational exposure to hydrocarbons and mixed solvents. QJM 1995, 88:23-28.
69. Donaghy M., Rees A.J. Cigarette smoking and lung haemorrhage in glomerulonephritis caused by autoantibodies to glomerular basement membrane. Lancet 1983, 2:1390-1393.
70. Hellmark T., Niles J.L., Collins A.B., McCluskey R.T., Brunmark C. Comparison of anti-GBM antibodies in sera with or without ANCA. J Am Soc Nephrol 1997, 8:376-385.
71. Cairns L.S., Phelps R.G., Bowie L., Hall A.M., Saweirs W.W., Rees A.J., et al. The fine specificity and cytokine profile of T-helper cells responsive to the alpha3 chain of type IV collagen in Goodpasture's disease. J Am Soc Nephrol 2003, 14:2801-2812.
72. Wong D., Phelps R.G., Turner A.N. The Goodpasture antigen is expressed in the human thymus. Kidney Int 2001, 60:1777-1783.
73. Zhang Y., Su S.C., Hecox D.B., Brady G.F., Mackin K.M., Clark A.G., et al. Central tolerance regulates B cells reactive with Goodpasture antigen alpha3(IV)NC1 collagen. J Immunol 2008, 181:6092-6100.
74. Zou J., Hannier S., Cairns L.S., Barker R.N., Rees A.J., Turner A.N., et al. Healthy individuals have Goodpasture autoantigen-reactive T cells. J Am Soc Nephrol 2008, 19:396-404.
75. Yang R., Cui Z., Hellmark T., Segelmark M., Zhao M.H., Wang H.Y. Natural anti-GBM antibodies from normal human sera recognize alpha3(IV)NC1 restrictively and recognize the same epitopes as anti-GBM antibodies from patients with anti-GBM disease. Clin Immunol 2007, 124:207-212.
76. Salama A.D., Chaudhry A.N., Ryan J.J., Eren E., Levy J.B., Pusey C.D., et al. In Goodpasture's disease, CD4(+) T cells escape thymic deletion and are reactive with the autoantigen alpha3(IV)NC1. J Am Soc Nephrol 2001, 12:1908-1915.
77. Wilson C.B., Dixon F.J. Anti-glomerular basement membrane antibody-induced glomerulonephritis. Kidney Int 1973, 3:74-89.
78. Salama A.D., Chaudhry A.N., Holthaus K.A., Mosley K., Kalluri R., Sayegh M.H., et al. Regulation by CD25+ lymphocytes of autoantigen-specific T-cell responses in Goodpasture's (anti-GBM) disease. Kidney Int 2003, 64:1685-1694.
79. Reynolds J., Pusey C.D. Oral administration of glomerular basement membrane prevents the development of experimental autoimmune glomerulonephritis in the WKY rat. J Am Soc Nephrol 2001, 12:61-70.
80. Reynolds J., Prodromidi E.I., Juggapah J.K., Abbott D.S., Holthaus K.A., Kalluri R., et al. Nasal administration of recombinant rat alpha3(IV)NC1 prevents the development of experimental autoimmune glomerulonephritis in the WKY rat. J Am Soc Nephrol 2005, 16:1350-1359.
81. Reynolds J., Abbott D.S., Karegli J., Evans D.J., Pusey C.D. Mucosal tolerance induced by an immunodominant peptide from rat alpha3(IV)NC1 in established experimental autoimmune glomerulonephritis. Am J Pathol 2009, 174:2202-2210.
82. Reynolds J., Khan S.B., Allen A.R., Benjamin C.D., Pusey C.D. Blockade of the CD154-CD40 costimulatory pathway prevents the development of experimental autoimmune glomerulonephritis. Kidney Int 2004, 66:1444-1452.
83. Reynolds J., Tam F.W., Chandraker A., Smith J., Karkar A.M., Cross J., et al. CD28-B7 blockade prevents the development of experimental autoimmune glomerulonephritis. J Clin Invest 2000, 105:643-651.
84. Holdsworth S.R., Kitching A.R., Tipping P.G. Th1 and Th2 T helper cell subsets affect patterns of injury and outcomes in glomerulonephritis. Kidney Int 1999, 55:1198-1216.
85. Huang X.R., Tipping P.G., Shuo L., Holdsworth S.R. Th1 responsiveness to nephritogenic antigens determines susceptibility to crescentic glomerulonephritis in mice. Kidney Int 1997, 51:94-103.
86. Tipping P.G., Huang X.R., Qi M., Van G.Y., Tang W.W. Crescentic glomerulonephritis in CD4- and CD8-deficient mice. Requirement for CD4 but not CD8 cells. Am J Pathol 1998, 152:1541-1548.
87. Tipping P.G., Holdsworth S.R. T cells in crescentic glomerulonephritis. J Am Soc Nephrol 2006, 17:1253-1263.
88. Fisher M., Pusey C.D., Vaughan R.W., Rees A.J. Susceptibility to anti-glomerular basement membrane disease is strongly associated with HLA-DRB1 genes. Kidney Int 1997, 51:222-229.
89. Kitagawa W., Imai H., Komatsuda A., Maki N., Wakui H., Hiki Y., et al. The HLA-DRB1*1501 allele is prevalent among Japanese patients with anti-glomerular basement membrane antibody-mediated disease. Nephrol Dial Transplant 2008, 23:3126-3129.
90. Yang R., Cui Z., Zhao J., Zhao M.H. The role of HLA-DRB1 alleles on susceptibility of Chinese patients with anti-GBM disease. Clin Immunol 2009, 133:245-250.
91. Phelps R.G., Jones V., Turner A.N., Rees A.J. Properties of HLA class II molecules divergently associated with Goodpasture's disease. Int Immunol 2000, 12:1135-1143.
92. Hopfer H., Maron R., Butzmann U., Helmchen U., Weiner H.L., Kalluri R. The importance of cell-mediated immunity in the course and severity of autoimmune anti-glomerular basement membrane disease in mice. FASEB J 2003, 17:860-868.
93. Reynolds J., Albouainain A., Duda M.A., Evans D.J., Pusey C.D. Strain susceptibility to active induction and passive transfer of experimental autoimmune glomerulonephritis in the rat. Nephrol Dial Transplant 2006, 21:3398-3408.
94. Aitman T.J., Dong R., Vyse T.J., Norsworthy P.J., Johnson M.D., Smith J., et al. Copy number polymorphism in Fcgr3 predisposes to glomerulonephritis in rats and humans. Nature 2006, 439:851-855.